Shuyi Si

4.2k total citations · 1 hit paper
86 papers, 3.5k citations indexed

About

Shuyi Si is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Shuyi Si has authored 86 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 26 papers in Oncology and 24 papers in Surgery. Recurrent topics in Shuyi Si's work include Peroxisome Proliferator-Activated Receptors (21 papers), Cholesterol and Lipid Metabolism (17 papers) and Drug Transport and Resistance Mechanisms (16 papers). Shuyi Si is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (21 papers), Cholesterol and Lipid Metabolism (17 papers) and Drug Transport and Resistance Mechanisms (16 papers). Shuyi Si collaborates with scholars based in China, United States and Germany. Shuyi Si's co-authors include Zhuorong Li, Weijia Kong, Jing Wei, Yanni Xu, Jian‐Dong Jiang, Bin Hong, Cong Li, Yanling Wang, Shukui Wang and Parveen Abidi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and PLoS ONE.

In The Last Decade

Shuyi Si

84 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

2004 1.2k citations Shuyi Si, Zhuorong Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuyi Si China	29	1.9k	1.3k	613	543	477	86	3.5k
Meihong Lin United States	17	1.5k 0.8×	861 0.7×	309 0.5×	371 0.7×	592 1.2×	21	3.1k
Guang Liang China	40	2.3k 1.2×	420 0.3×	364 0.6×	301 0.6×	529 1.1×	129	4.7k
Franco O. Ranelletti Italy	44	2.4k 1.3×	1.1k 0.8×	497 0.8×	228 0.4×	925 1.9×	128	6.0k
Toshihiko Kawamori Japan	42	3.1k 1.6×	2.1k 1.6×	606 1.0×	351 0.6×	977 2.0×	85	6.5k
Chin‐Wen Chi Taiwan	32	1.5k 0.8×	670 0.5×	207 0.3×	386 0.7×	598 1.3×	80	3.0k
Michihiro Mutoh Japan	33	2.2k 1.1×	937 0.7×	578 0.9×	216 0.4×	954 2.0×	168	4.8k
Jun‐Yan Liu China	36	1.1k 0.6×	857 0.7×	205 0.3×	475 0.9×	332 0.7×	127	4.1k
Richard Lehner Canada	40	2.2k 1.2×	484 0.4×	1.1k 1.7×	229 0.4×	417 0.9×	91	5.1k
Kishore Banik India	35	2.0k 1.1×	646 0.5×	127 0.2×	519 1.0×	522 1.1×	46	3.7k
Yen‐Chou Chen Taiwan	32	2.0k 1.0×	677 0.5×	149 0.2×	250 0.5×	335 0.7×	83	3.6k

Countries citing papers authored by Shuyi Si

Since Specialization

Citations

This map shows the geographic impact of Shuyi Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyi Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyi Si more than expected).

Fields of papers citing papers by Shuyi Si

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyi Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyi Si. The network helps show where Shuyi Si may publish in the future.

Co-authorship network of co-authors of Shuyi Si

This figure shows the co-authorship network connecting the top 25 collaborators of Shuyi Si. A scholar is included among the top collaborators of Shuyi Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyi Si. Shuyi Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Dongsheng, Yan Li, Xiaofang Chen, et al.. (2025). Establishment of a Yeast Two-Hybrid-Based High-Throughput Screening Model for Selection of SARS-CoV-2 Spike-ACE2 Interaction Inhibitors. International Journal of Molecular Sciences. 26(2). 678–678.

Zhang, Yuyan, Xinwei Wei, Ren Sheng, et al.. (2025). A Novel RANKL/RANK Inhibitor IMB-R38 Inhibits Osteoporosis Through Regulating Bone Metabolism. International Journal of Molecular Sciences. 26(24). 12151–12151.

Li, Shunwang, Jinque Luo, Huan Liu, et al.. (2024). ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet–Fed ApoE ^−/− Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux. Arteriosclerosis Thrombosis and Vascular Biology. 44(12). 2428–2449. 9 indexed citations

Yang, Xu, et al.. (2024). Trichostatin C Synergistically Interacts with DNMT Inhibitor to Induce Antineoplastic Effect via Inhibition of Axl in Bladder and Lung Cancer Cells. Pharmaceuticals. 17(4). 425–425. 2 indexed citations

Wang, Weizhi, Chao Liu, Jinque Luo, et al.. (2024). A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis. Acta Pharmacologica Sinica. 45(10). 2119–2133. 38 indexed citations

Luo, Jinque, Huan Liu, Yanni Xu, et al.. (2024). Hepatic Sirt6 activation abrogates acute liver failure. Cell Death and Disease. 15(4). 283–283. 7 indexed citations

Sheng, Ren, Yining Li, Chang Liu, et al.. (2024). A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue. Biomedicine & Pharmacotherapy. 172. 116220–116220. 7 indexed citations

Wang, Weizhi, Tingting Feng, Peng Liu, et al.. (2024). Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway. International Journal of Biological Sciences. 20(10). 3725–3741. 8 indexed citations

Liu, Chao, Yining Li, Ren Sheng, et al.. (2021). Synthesis of N-methylpyridine-chlorofuranformamide analogs as novel OPG up-regulators and inhibitors of RANKL-induced osteoclastogenesis. Bioorganic Chemistry. 116. 105361–105361. 2 indexed citations

10.

Wang, Junxia, Minghua Chen, Wenxia Zhao, et al.. (2021). The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP via ER stress in pancreatic cancer cells. Acta Pharmaceutica Sinica B. 12(1). 210–227. 23 indexed citations

11.

Li, Yining, Weizhi Wang, Xiaowan Han, et al.. (2020). Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid Metabolism. Frontiers in Pharmacology. 11. 532568–532568. 15 indexed citations

12.

Zhang, Jin, Yu Du, Xiaojian Jia, et al.. (2015). microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator. Atherosclerosis. 243(2). 523–532. 59 indexed citations

13.

Chen, Minghua, Yi He, Yanni Xu, et al.. (2014). Identification of trichostatin derivatives from Streptomyces sp. CPCC 203909. Bioorganic & Medicinal Chemistry Letters. 25(3). 562–565. 13 indexed citations

14.

Lai, Fangfang, Qiqi Ye, Qiming Duan, et al.. (2013). Identification of a Mutant α1 Na/K-ATPase That Pumps but Is Defective in Signal Transduction. Journal of Biological Chemistry. 288(19). 13295–13304. 54 indexed citations

15.

Hong, Bin & Shuyi Si. (2011). Establishment of a high-throughput screening model for identifying up-regulator of human Apo A-I expression. 1 indexed citations

16.

Zheng, Zhihui, Yi Yang, Zongying Liu, et al.. (2011). Two Thiophenes Compounds Are Partial Peroxisome Proliferator-Activated Receptor .ALPHA./.GAMMA. Dual Agonists. Biological and Pharmaceutical Bulletin. 34(10). 1631–1634. 5 indexed citations

17.

Wang, Li, et al.. (2010). Discovery of Antagonists for Human Scavenger Receptor CD36 via an ELISA-Like High-Throughput Screening Assay. SLAS DISCOVERY. 15(3). 239–250. 42 indexed citations

18.

Li, Xue, Jun Yang, Xiaobo He, et al.. (2009). Identification of Upregulators of BMP2 Expression via High-Throughput Screening of a Synthetic and Natural Compound Library. SLAS DISCOVERY. 14(10). 1251–1256. 31 indexed citations

19.

Liu, Zong‐Ying, Xiaobo He, Zhaoyong Yang, et al.. (2009). Synthesis and evaluation of 1-(benzo[b]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor. Bioorganic & Medicinal Chemistry Letters. 19(15). 4167–4170. 14 indexed citations

20.

Zheng, Zhihui, et al.. (2007). A cell-based high-throughput screening assay for Farnesoid X receptor agonists.. PubMed. 20(6). 465–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact